Schedule 13G ownership disclosure

NOVELION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 67001K202

Event date: 2018-11-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,890,525
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-064823
Form type
SC 13G/A
Filer
NB Public Equity K/S
CIK
CIK 1451330
Filed
Dec 17, 2018
Reporting period
Nov 09, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub